Figure 5.
PFS curves in discordant patients (ZAP-70+CD38–/ZAP-70–CD38+and ZAP-70+M/ZAP-70–UM) and in ZAP-70–patients by sCD23 levels. (A-B) Interestingly, ZAP-70– either CD38+ or UM patients showed a longer PFS in comparison with ZAP-70+ either CD38– or M patients (P < .001 and P = .002, respectively). In panel A, the gray line indicates ZAP-70+CD38–; the black line, ZAP-70–CD38+. In panel B, the gray line indicates ZAP-70+ M; the black line, ZAP-70– UM. (C) Levels lower than 70 U/mL of sCD23 identified patients with a longer PFS within the ZAP-70– subset (P < .001). Black line indicates sCD23 < 70 U/mL; gray line, sCD23 > 70 U/mL.

PFS curves in discordant patients (ZAP-70+CD38/ZAP-70CD38+and ZAP-70+M/ZAP-70UM) and in ZAP-70patients by sCD23 levels. (A-B) Interestingly, ZAP-70 either CD38+ or UM patients showed a longer PFS in comparison with ZAP-70+ either CD38 or M patients (P < .001 and P = .002, respectively). In panel A, the gray line indicates ZAP-70+CD38; the black line, ZAP-70CD38+. In panel B, the gray line indicates ZAP-70+ M; the black line, ZAP-70 UM. (C) Levels lower than 70 U/mL of sCD23 identified patients with a longer PFS within the ZAP-70 subset (P < .001). Black line indicates sCD23 < 70 U/mL; gray line, sCD23 > 70 U/mL.

Close Modal

or Create an Account

Close Modal
Close Modal